The vaccine should be injected intramuscularly or subcutaneously .
The recommended intramuscular injection site for children aged 6 to 35 months is the anterolateral thigh (or the deltoid muscle if muscle mass is sufficient), and for children aged 36 months and older the deltoid muscle .
Annual influenza vaccination is recommended. Before vaccination, an examination is indicated, to exclude contact with SARS patients.
Patients should be under medical supervision for 30 minutes after administration of the vaccine.
Vaxiflu Tetra vaccine is indicated for the prevention of influenza caused by the two subtypes of influenza A virus and the two types of influenza B virus contained in this vaccine for:
Hypersensitivity to any component of the vaccine, to the components of chicken eggs, if complications were detected after previous vaccination.
Vaccination is not given to children who have acute infectious diseases accompanied by fever, progressive diseases (acute or chronic).
After vaccination can be observed:
In the presence of mechanical inclusions or a strange color of the suspension, the use of the vaccine is unacceptable.